Cannapharmarx, Inc. SEC filings CPMD
Cannapharmarx, Inc. has 365 filings in SEC EDGAR's recent list, going back to Jun 10, 1999. Its latest annual report, Form 10-K, was filed on Mar 31, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 18, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Jan 13, 2026 (officer or director change, other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Officer or director change, Other events
|
Jan 13, 2026 | Jan 8, 2026 |
| 8-K |
Current report
Other events
|
Dec 18, 2025 | Dec 12, 2025 |
| 8-K |
Current report
Other events
|
Oct 10, 2025 | Aug 7, 2025 |
| 8-K |
Current report
Other events
|
May 6, 2025 | May 6, 2025 |
| 8-K |
Current report
Officer or director change
|
Mar 31, 2025 | Mar 26, 2025 |
| 8-K |
Current report
Auditor change
|
Dec 3, 2024 | Nov 29, 2024 |
| 8-K |
Current report
Auditor change
|
Nov 21, 2024 | Nov 20, 2024 |
| 8-K |
Current report
Officer or director change
|
Sep 17, 2024 | Sep 9, 2024 |
| 8-K/A | Amended current report | Feb 22, 2024 | Feb 15, 2024 |
| 8-K |
Current report
Material agreement
|
Feb 16, 2024 | Feb 15, 2024 |
| 8-K |
Current report
Material agreement, Acquisition or sale of assets, Unregistered share sale
|
Dec 6, 2023 | Nov 22, 2023 |
| 8-K |
Current report
Auditor change
|
Nov 13, 2023 | Nov 6, 2023 |
| 8-K |
Current report
Officer or director change
|
Oct 13, 2023 | Oct 9, 2023 |
| 8-K |
Current report
Officer or director change
|
Aug 28, 2023 | Mar 23, 2023 |
| 8-K |
Current report
Officer or director change
|
Jun 23, 2023 | Jun 1, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Feb 16, 2022 | Feb 14, 2022 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Jul 16, 2021 | Jul 13, 2021 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Jun 22, 2021 | Jun 22, 2021 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Jun 9, 2021 | Jun 8, 2021 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Jan 28, 2021 | Jan 28, 2021 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Jan 22, 2021 | Jan 22, 2021 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Jan 12, 2021 | Jan 12, 2021 |
| 8-K |
Current report
Material agreement, New debt, Regulation FD disclosure
|
Aug 20, 2020 | Aug 20, 2020 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Jul 6, 2020 | Jun 30, 2020 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Jun 10, 2020 | Jun 6, 2020 |
| 8-K |
Current report
Regulation FD disclosure
|
May 20, 2020 | May 19, 2020 |
| 8-K |
Current report
Other events
|
May 14, 2020 | May 14, 2020 |
| 8-K |
Current report
Other events
|
Mar 27, 2020 | Mar 26, 2020 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Mar 17, 2020 | Mar 16, 2020 |
| 8-K |
Current report
Material agreement, New debt
|
Feb 10, 2020 | Jan 16, 2020 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Feb 7, 2020 | Nov 27, 2019 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Oct 3, 2019 | Oct 2, 2019 |
| 8-K |
Current report
Material agreement
|
Jun 12, 2019 | Jun 11, 2019 |
| 8-K |
Current report
Officer or director change
|
Apr 26, 2019 | Apr 23, 2019 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Officer or director change
|
Mar 1, 2019 | Feb 25, 2019 |
| 8-K/A |
Amended current report
Material agreement, Unregistered share sale, Regulation FD disclosure
|
Feb 14, 2019 | Nov 19, 2018 |
| 8-K |
Current report
Unregistered share sale
|
Jan 30, 2019 | Jan 17, 2019 |
| 8-K/A |
Amended current report
Material agreement, Unregistered share sale, Regulation FD disclosure
|
Jan 7, 2019 | Nov 19, 2018 |
| 8-K |
Current report
Material agreement, Officer or director change
|
Nov 21, 2018 | Nov 19, 2018 |
| 8-K |
Current report
Auditor change, Officer or director change
|
Jun 15, 2018 | Apr 20, 2018 |
| 8-K |
Current report
Other events
|
Apr 13, 2018 | Apr 12, 2018 |
| 8-K |
Current report
Officer or director change
|
Jun 2, 2016 | Jan 11, 2016 |
| 8-K |
Current report
Officer or director change
|
Apr 15, 2016 | Apr 6, 2016 |
| 8-K |
Current report
Officer or director change
|
Jan 13, 2016 | Dec 18, 2015 |
| 8-K/A |
Amended current report
Shareholder vote results
|
Oct 6, 2015 | Oct 6, 2015 |
| 8-K |
Current report
Shareholder vote results
|
Aug 31, 2015 | Aug 28, 2015 |
| 8-K |
Current report
Other events
|
Jul 7, 2015 | Jul 1, 2015 |
| 8-K |
Current report
Unregistered share sale, Change in control
|
Jul 2, 2015 | Jun 29, 2015 |
| 8-K/A |
Amended current report
Material agreement
|
May 28, 2015 | Mar 30, 2015 |
| 8-K |
Current report
Other events
|
May 27, 2015 | May 20, 2015 |
| 8-K |
Current report
Unregistered share sale
|
Apr 29, 2015 | Apr 23, 2015 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Change in control
|
Apr 24, 2015 | Apr 21, 2015 |
| 8-K |
Current report
Officer or director change
|
Apr 6, 2015 | Apr 1, 2015 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Apr 3, 2015 | Mar 30, 2015 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Mar 23, 2015 | Mar 23, 2015 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Mar 3, 2015 | Feb 26, 2015 |
| 8-K |
Current report
Officer or director change
|
Feb 12, 2015 | Feb 9, 2015 |
| 8-K |
Current report
Regulation FD disclosure
|
Dec 17, 2014 | Dec 15, 2014 |
| 8-K |
Current report
Regulation FD disclosure
|
Dec 12, 2014 | Dec 1, 2014 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Dec 9, 2014 | Dec 5, 2014 |
| 8-K |
Current report
Other events
|
Nov 21, 2014 | Nov 20, 2014 |
| 8-K |
Current report
Officer or director change
|
Oct 27, 2014 | Oct 23, 2014 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Oct 24, 2014 | Oct 23, 2014 |
| 8-K |
Current report
Officer or director change
|
Sep 29, 2014 | Sep 23, 2014 |
| 8-K |
Current report
Unregistered share sale, Officer or director change
|
Sep 19, 2014 | Sep 18, 2014 |
| 8-K |
Current report
Unregistered share sale
|
Jun 20, 2014 | Jun 19, 2014 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Officer or director change
|
Jun 4, 2014 | May 15, 2014 |
| 8-K |
Current report
Unregistered share sale, Change in control, Officer or director change, Other events
|
May 16, 2014 | May 9, 2014 |
| 8-K/A |
Amended current report
Auditor change
|
Jan 31, 2014 | Jan 20, 2014 |
| 8-K |
Current report
Auditor change
|
Jan 27, 2014 | Jan 20, 2014 |
| 8-K |
Current report
Material agreement, Acquisition or sale of assets, Unregistered share sale
|
Jan 28, 2011 | Dec 31, 2010 |
| 8-K/A |
Amended current report
Auditor change
|
Jan 12, 2011 | Nov 10, 2010 |
| 8-K | Current report | Nov 17, 2010 | Nov 10, 2010 |
| 8-K |
Current report
Material agreement, Bylaw or fiscal year change
|
Oct 14, 2010 | Sep 29, 2010 |
| 8-K |
Current report
Officer or director change
|
Jan 22, 2009 | Jan 6, 2009 |
| 8-K |
Current report
Unregistered share sale
|
Aug 28, 2008 | Aug 22, 2008 |
| 8-K |
Current report
Other events
|
May 5, 2008 | Apr 29, 2008 |
| 8-K |
Current report
Unregistered share sale
|
Dec 3, 2007 | Dec 3, 2007 |
| 8-K | Current report | Feb 26, 2001 | Feb 16, 2001 |
| 8-K | Current report | Dec 22, 2000 | Dec 18, 2000 |
| 8-K | Current report | Jul 25, 2000 | Jul 21, 2000 |
Showing 81 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- CPMD (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Mountain View County
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1081938
- Former names
- GOLDEN DRAGON HOLDING CO. (until Oct 27, 2014); CCVG, INC. (until Jan 12, 2011); CONCORD VENTURES, INC. (until Nov 17, 2010); CAVION TECHNOLOGIES INC (until Jul 25, 2007)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.